marketcaparena
Search

    BTMD

    biote Corp.

    Company overview

    Market capitalization
    —
    Employees
    223
    Latest publication
    2026-09-29
    About biote Corp.

    biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ2 20252025-06-30 · USDQ4 20242024-12-31 · USDQ3 20222022-09-30 · USDQ1 20222022-03-31 · USDQ4 20212021-12-31 · USDQ3 20212021-09-30 · USD
    Total Revenue44,935,000USD46,408,000USD48,863,000USD49,834,000USD41,970,000USD37,143,000USD37,536,000USD35,567,000USD
    Cost Of Revenue13,982,000USD14,835,000USD13,875,000USD14,304,000USD13,337,000USD12,277,000USD13,526,000USD12,290,000USD
    Gross Profit30,953,000USD31,573,000USD34,988,000USD35,530,000USD28,633,000USD24,866,000USD24,010,000USD23,277,000USD
    Selling General Administrative27,787,000USD24,744,000USD24,223,000USD32,763,000USD19,612,000USD15,103,000USD17,636,000USD12,311,000USD
    Total Operating Expenses27,787,000USD24,744,000USD24,223,000USD32,763,000USD20,818,000USD15,103,000USD31,611,000USD14,294,000USD
    Operating Income3,166,000USD6,829,000USD10,765,000USD2,767,000USD7,815,000USD9,763,000USD5,925,000USD8,983,000USD
    Interest Expense1,972,000USD2,471,000USD2,852,000USD3,222,000USD1,756,000USD359,000USD372,000USD384,000USD
    Net Interest Income-1,972,000USD-2,471,000USD-2,852,000USD-3,222,000USD-1,756,000USD-359,000USD-372,000USD-384,000USD
    Income Before Tax3,338,000USD5,603,000USD6,075,000USD-1,220,000USD-6,112,000USD9,414,000USD5,557,000USD8,604,000USD
    Income Tax Expense662,000USD2,986,000USD2,150,000USD-4,703,000USD234,000USD64,000USD77,000USD67,000USD
    Tax Provision662,000USD2,986,000USD2,150,000USD-4,703,000USD234,000USD64,000USD77,000USD67,000USD
    Net Income2,277,000USD1,954,000USD3,185,000USD3,703,000USD-6,346,000USD9,350,000USD5,480,000USD8,537,000USD
    Net Income From Continuing Ops2,676,000USD2,617,000USD3,925,000USD3,483,000USD-6,346,000USD9,350,000USD5,480,000USD8,537,000USD
    Ebit5,310,000USD8,074,000USD8,927,000USD2,002,000USD7,815,000USD9,773,000USD5,925,000USD8,988,000USD
    Ebitda6,290,000USD9,025,000USD9,837,000USD3,140,000USD8,751,000USD10,275,000USD5,929,000USD9,320,000USD
    Depreciation And Amortization980,000USD951,000USD910,000USD1,138,000USD936,000USD502,000USD—332,000USD
    Reconciled Depreciation980,000USD951,000USD910,000USD1,138,000USD580,000USD502,000USD413,000USD332,000USD
    Total Other Income Expense Net172,000USD-1,226,000USD-4,690,000USD-3,987,000USD-13,927,000USD-349,000USD4,000USD-379,000USD
    Minority Interest-399,000USD-663,000USD-740,000USD220,000USD-6,890,000USD———
    Selling And Marketing Expenses————997,000USD——1,417,000USD
    Net Income Applicable To Common Shares————-13,236,000USD115,456,000USD5,480,000USD—
    Unclassified Operating Expenses——————13,975,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Revenue139,396,000USD116,568,000USD109,976,000USD
    Cost Of Revenue48,817,000USD44,929,000USD43,565,000USD
    Gross Profit90,579,000USD71,639,000USD66,411,000USD
    Selling General Administrative49,054,000USD33,017,000USD32,028,000USD
    Selling And Marketing Expenses4,908,000USD4,409,000USD7,264,000USD
    Unclassified Operating Expenses2,056,000USD2,432,000USD3,592,000USD
    Total Operating Expenses56,018,000USD39,858,000USD42,884,000USD
    Operating Income34,561,000USD31,781,000USD23,527,000USD
    Interest Expense1,673,000USD2,425,000USD2,082,000USD
    Net Interest Income-1,673,000USD-2,425,000USD-2,082,000USD
    Income Before Tax32,905,000USD29,351,000USD21,380,000USD
    Income Tax Expense286,000USD189,000USD93,000USD
    Tax Provision286,000USD189,000USD93,000USD
    Net Income32,619,000USD29,162,000USD21,287,000USD
    Net Income From Continuing Ops32,619,000USD29,162,000USD21,287,000USD
    Ebit34,578,000USD31,776,000USD23,462,000USD
    Ebitda35,978,000USD32,914,000USD24,294,000USD
    Depreciation And Amortization1,400,000USD1,138,000USD832,000USD
    Reconciled Depreciation1,400,000USD1,138,000USD832,000USD
    Total Other Income Expense Net-1,656,000USD-2,430,000USD-2,147,000USD
    Net Income Applicable To Common Shares32,619,000USD29,162,000USD21,287,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets89,032,000USD107,613,000USD111,324,000USD104,798,000USD123,379,000USD122,370,000USD101,252,000USD92,900,000USD
    Intangible Assets9,031,000USD8,791,000USD8,068,000USD8,465,000USD8,952,000USD9,377,000USD10,640,000USD10,851,000USD
    Other Current Assets3,758,000USD3,806,000USD4,315,000USD8,599,000USD5,764,000USD6,238,000USD6,663,000USD7,547,000USD
    Total Liab136,987,000USD158,010,000USD176,791,000USD183,638,000USD208,205,000USD224,570,000USD228,076,000USD234,551,000USD
    Total Stockholder Equity-56,091,000USD-58,539,000USD-72,751,000USD-85,104,000USD-89,981,000USD-105,928,000USD-130,342,000USD-143,341,000USD
    Other Current Liab10,282,000USD28,306,000USD41,960,000USD36,815,000USD34,274,000USD35,967,000USD32,271,000USD30,645,000USD
    Common Stock4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Capital Stock4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Retained Earnings-46,032,000USD-49,549,000USD-63,760,000USD-79,478,000USD-84,346,000USD-100,297,000USD-124,717,000USD-137,723,000USD
    Good Will5,833,000USD5,833,000USD5,833,000USD5,833,000USD5,833,000USD5,833,000USD5,516,000USD5,516,000USD
    Cash5,320,000USD24,123,000USD28,048,000USD19,601,000USD41,700,000USD39,342,000USD38,225,000USD26,419,000USD
    Cash And Short Term Investments5,320,000USD24,123,000USD28,048,000USD19,601,000USD41,700,000USD39,342,000USD38,225,000USD26,419,000USD
    Total Current Assets36,356,000USD54,670,000USD57,123,000USD49,504,000USD68,680,000USD68,127,000USD69,983,000USD61,767,000USD
    Total Current Liabilities28,226,000USD44,991,000USD56,308,000USD50,537,000USD48,470,000USD51,514,000USD46,510,000USD46,266,000USD
    Current Deferred Revenue2,848,000USD3,017,000USD3,165,000USD3,052,000USD3,036,000USD2,961,000USD2,927,000USD3,159,000USD
    Net Debt103,102,000USD85,799,000USD78,358,000USD88,293,000USD67,684,000USD71,520,000USD84,081,000USD95,966,000USD
    Short Term Debt6,860,000USD6,842,000USD6,824,000USD6,807,000USD6,790,000USD6,773,000USD6,732,000USD6,669,000USD
    Short Long Term Debt6,250,000USD6,250,000USD6,250,000USD6,250,000USD6,250,000USD6,250,000USD6,250,000USD6,250,000USD
    Short Long Term Debt Total108,422,000USD109,922,000USD106,406,000USD107,894,000USD109,384,000USD110,862,000USD122,306,000USD122,385,000USD
    Long Term Debt99,425,000USD100,782,000USD97,130,000USD98,486,000USD99,847,000USD101,199,000USD112,548,000USD113,909,000USD
    Net Receivables7,397,000USD7,677,000USD8,314,000USD9,172,000USD7,765,000USD7,702,000USD8,895,000USD8,589,000USD
    Inventory19,881,000USD19,064,000USD16,446,000USD12,132,000USD13,451,000USD14,845,000USD16,200,000USD19,212,000USD
    Accounts Payable8,236,000USD6,826,000USD4,359,000USD3,863,000USD3,335,000USD5,813,000USD4,374,000USD5,793,000USD
    Property Plant Equipment Net13,259,000USD13,454,000USD12,904,000USD12,906,000USD11,502,000USD10,219,000USD9,189,000USD6,625,000USD
    Property Plant Equipment Gross21,313,000USD21,094,000USD20,157,000USD19,795,000USD18,121,000USD16,624,000USD15,289,000USD12,550,000USD
    Accumulated Other Comprehensive Income-27,000USD-29,000USD-30,000USD-30,000USD-39,000USD-35,000USD-29,000USD-22,000USD
    Common Stock Shares Outstanding35,995,490shares30,826,891shares36,708,867shares36,959,000shares36,953,000shares37,290,059shares32,261,000shares33,072,156shares
    Non Current Assets Total52,675,999USD52,943,000USD54,201,000USD55,294,000USD54,699,000USD54,243,000USD31,269,000USD31,133,000USD
    Non Current Liabilities Total108,761,000USD113,019,000USD120,483,000USD133,101,000USD159,735,000USD173,056,000USD181,566,000USD188,285,000USD
    Non Current Liabilities Other6,277,000USD8,842,000USD19,668,000USD30,612,000USD55,691,000USD67,414,000USD64,389,000USD71,025,000USD
    Non Currrent Assets Other71,999USD72,000USD72,000USD72,000USD72,000USD72,000USD4,974,000USD4,884,000USD
    Net Working Capital8,130,000USD9,679,000USD815,000USD-1,033,000USD20,210,000USD16,613,000USD23,473,000USD15,501,000USD
    Unclassified Non Current Assets24,481,000USD24,793,000USD27,324,000USD28,018,000USD28,340,000USD28,742,000USD—3,257,000USD
    Unclassified Current Liabilities-6,250,000USD-6,250,000USD-6,250,000USD-6,250,000USD-5,215,000USD-6,250,000USD-6,044,000USD-6,250,000USD
    Unclassified Non Current Liabilities3,059,000USD3,395,000USD3,685,000USD4,003,000USD4,197,000USD4,443,000USD4,629,000USD3,351,000USD
    Unclassified Equity-10,040,000USD-8,969,000USD-8,969,000USD-5,604,000USD-5,604,000USD-5,604,000USD-5,604,000USD-5,604,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets107,613,000USD122,370,000USD155,295,000USD111,645,000USD54,330,000USD32,587,000USD23,891,000USD
    Intangible Assets4,266,000USD9,377,000USD4,973,000USD5,073,000USD4,554,000USD2,600,000USD1,824,000USD
    Other Current Assets3,806,000USD6,238,000USD7,860,000USD3,816,000USD5,473,000USD1,570,000USD884,000USD
    Total Liab158,010,000USD224,570,000USD191,841,000USD169,919,000USD50,205,000USD49,662,000USD56,819,000USD
    Total Stockholder Equity-58,539,000USD-105,928,000USD-29,397,000USD-44,459,000USD4,125,000USD-17,075,000USD-32,928,000USD
    Other Current Liab28,306,000USD35,967,000USD8,480,000USD5,224,000USD6,011,000USD1,982,000USD5,094,000USD
    Common Stock4,000USD4,000USD6,000USD6,000USD317,500,794USD——
    Capital Stock4,000USD4,000USD6,000USD6,000USD0USD0USD—
    Retained Earnings-49,549,000USD-100,297,000USD-29,391,000USD-44,460,000USD4,165,000USD-17,052,000USD-32,895,000USD
    Good Will5,833,000USD5,833,000USD0USD————
    Cash24,123,000USD39,342,000USD89,002,000USD79,231,000USD26,766,000USD17,208,000USD10,486,000USD
    Cash And Short Term Investments24,123,000USD39,342,000USD89,002,000USD79,231,000USD26,766,000USD17,208,000USD10,486,000USD
    Total Current Assets54,670,000USD68,127,000USD122,343,000USD101,178,000USD47,085,000USD27,822,000USD19,303,000USD
    Total Current Liabilities44,991,000USD51,514,000USD22,215,000USD18,766,000USD17,313,000USD11,710,000USD13,513,000USD
    Current Deferred Revenue3,017,000USD2,961,000USD3,002,000USD1,965,000USD1,705,000USD2,044,000USD—
    Net Debt85,799,000USD71,520,000USD25,869,000USD41,197,000USD10,572,000USD25,147,000USD36,647,000USD
    Short Term Debt6,842,000USD6,773,000USD6,561,000USD6,415,000USD5,248,000USD5,239,000USD5,230,000USD
    Short Long Term Debt6,250,000USD6,250,000USD6,250,000USD6,250,000USD5,000,000USD5,000,000USD—
    Short Long Term Debt Total109,922,000USD110,862,000USD114,871,000USD120,428,000USD37,338,000USD42,355,000USD47,133,000USD
    Long Term Debt100,782,000USD101,199,000USD106,630,000USD112,086,000USD31,963,000USD36,741,000USD—
    Net Receivables7,677,000USD7,702,000USD8,174,000USD6,948,000USD5,231,000USD4,720,000USD4,016,000USD
    Inventory19,064,000USD14,845,000USD17,307,000USD11,183,000USD9,615,000USD4,324,000USD3,917,000USD
    Accounts Payable6,826,000USD5,813,000USD4,155,000USD4,112,000USD4,349,000USD2,445,000USD3,189,000USD
    Property Plant Equipment Net13,454,000USD10,219,000USD3,095,000USD3,556,000USD2,691,000USD2,165,000USD2,764,000USD
    Property Plant Equipment Gross21,094,000USD16,624,000USD8,709,000USD3,556,000USD6,337,000USD5,098,000USD—
    Accumulated Other Comprehensive Income-29,000USD-35,000USD-12,000USD-5,000USD-40,000USD-23,000USD-33,000USD
    Common Stock Shares Outstanding36,666,766shares34,270,809shares25,709,343shares8,059,371shares7,574,271shares7,574,271shares7,574,271shares
    Non Current Assets Total52,943,000USD54,243,000USD32,952,000USD10,467,000USD7,245,000USD4,765,000USD4,588,000USD
    Non Current Liabilities Total113,019,000USD173,056,000USD169,626,000USD151,153,000USD32,892,000USD37,952,000USD43,306,000USD
    Non Current Liabilities Other8,842,000USD67,414,000USD59,994,000USD32,110,000USD———
    Non Currrent Assets Other4,597,000USD72,000USD4,972,999USD5,073,000USD-317,581,791USD-4,765,000USD-4,588,000USD
    Net Working Capital9,679,000USD16,613,000USD100,128,000USD82,412,000USD29,772,000USD16,112,000USD—
    Unclassified Non Current Assets24,793,000USD28,742,000USD19,911,000USD-3,235,000USD———
    Unclassified Current Liabilities-6,250,000USD-6,250,000USD-6,233,000USD-5,200,000USD-5,000,000USD-5,000,000USD—
    Unclassified Non Current Liabilities3,395,000USD4,443,000USD3,002,000USD-30,183,000USD——42,133,000USD
    Unclassified Equity-8,969,000USD-5,604,000USD——-317,500,794USD——
    Other Assets——1USD————
    Other Liab———37,140,000USD802,000USD836,000USD1,173,000USD
    Net Tangible Assets———-49,532,000USD-429,000USD-19,675,000USD-34,752,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income2,277,000USD2,617,000USD9,216,000USD3,925,000USD15,839,000USD3,483,000USD4,955,000USD-10,368,000USD
    Depreciation980,000USD951,000USD952,000USD910,000USD857,000USD1,138,000USD810,000USD876,000USD
    Stock Based Compensation1,758,000USD2,198,000USD2,410,000USD2,186,000USD2,127,000USD1,886,000USD2,245,000USD2,841,000USD
    Other Non Cash Items-1,194,000USD791,000USD-1,380,000USD3,936,000USD-8,157,000USD2,595,000USD3,155,000USD15,393,000USD
    Change To Account Receivables-96,000USD969,000USD479,000USD-1,499,000USD-907,000USD283,000USD-866,000USD-355,000USD
    Change To Inventory301,000USD-3,710,000USD-4,145,000USD661,000USD952,000USD1,535,000USD2,371,000USD-267,000USD
    Change In Working Capital2,045,000USD-1,924,000USD3,120,000USD-4,648,000USD-4,707,000USD8,397,000USD2,158,000USD1,205,000USD
    Total Cash From Operating Activities3,902,000USD7,569,000USD14,072,000USD7,086,000USD6,467,000USD12,368,000USD15,556,000USD9,947,000USD
    Capital Expenditures-1,168,000USD-1,077,000USD-690,000USD-1,809,000USD-1,630,000USD-1,080,000USD-1,974,000USD-2,848,000USD
    Free Cash Flow2,734,000USD6,492,000USD13,382,000USD5,277,000USD4,837,000USD11,288,000USD13,582,000USD7,099,000USD
    Total Cashflows From Investing Activities-1,168,000USD-2,364,000USD-690,000USD-1,962,000USD-1,848,000USD-1,311,000USD-1,974,000USD-3,337,000USD
    Net Borrowings-1,563,000USD3,437,000USD-1,562,000USD-1,562,000USD-1,563,000USD-11,563,000USD-1,562,000USD—
    Total Cash From Financing Activities-21,539,000USD-9,131,000USD-4,935,000USD-27,232,000USD-2,257,000USD-9,934,000USD-1,768,000USD-58,972,000USD
    Dividends Paid-405,000USD-138,000USD-8,000USD-887,000USD-694,000USD-88,000USD-4,203,000USD-4,120,000USD
    Sale Purchase Of Stock-1,071,000USD0USD-3,365,000USD0USD0USD0USD0USD-1,511,000USD
    Change In Cash-18,803,000USD-3,925,000USD8,447,000USD-22,099,000USD2,358,000USD1,117,000USD11,806,000USD-52,368,000USD
    Begin Period Cash Flow24,123,000USD28,048,000USD19,601,000USD41,700,000USD39,342,000USD38,225,000USD26,419,000USD78,787,000USD
    End Period Cash Flow5,320,000USD24,123,000USD28,048,000USD19,601,000USD41,700,000USD39,342,000USD38,225,000USD26,419,000USD
    Other Cashflows From Investing Activities-806,000USD-1,287,000USD-191,000USD-153,000USD-218,000USD590,000USD-1,116,000USD-342,000USD
    Other Cashflows From Financing Activities-18,500,000USD-12,500,000USD1,573,000USD-25,081,000USD-2,257,000USD-4,669,000USD3,750,000USD-61,924,000USD
    Unclassified Operating Cash Flow-1,964,000USD2,936,000USD———-5,131,000USD2,233,000USD—
    Issuance Of Capital Stock—70,000USD0USD——136,000USD0USD—
    Investments——-690,000USD-1,962,000USD-1,848,000USD-1,311,000USD-1,974,000USD-3,337,000USD
    Unclassified Financing Cash Flow——-1,573,000USD—2,257,000USD6,386,000USD—8,583,000USD
    Unclassified Investing Cash Flow———1,962,000USD1,848,000USD—3,090,000USD3,190,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income27,045,000USD46,000USD3,316,000USD1,324,000USD32,619,000USD29,162,000USD21,287,000USD
    Depreciation3,670,000USD3,574,000USD2,994,000USD2,199,000USD1,400,000USD1,138,000USD832,000USD
    Stock Based Compensation8,921,000USD8,735,000USD9,057,000USD82,180,000USD0USD——
    Other Non Cash Items-165,000USD25,852,000USD19,722,000USD-58,303,000USD1,159,000USD1,713,000USD837,000USD
    Change To Account Receivables-958,000USD-2,267,000USD-505,000USD-1,562,000USD-752,000USD-1,481,000USD-714,000USD
    Change To Inventory-6,242,000USD3,714,000USD-6,098,000USD-1,708,000USD-5,762,000USD-904,000USD1,299,000USD
    Change In Working Capital-8,252,000USD9,934,000USD-8,927,000USD-35,814,000USD-1,458,000USD-5,588,000USD2,398,000USD
    Total Cash From Operating Activities35,194,000USD45,243,000USD26,883,000USD-9,157,000USD33,720,000USD26,425,000USD25,354,000USD
    Capital Expenditures-5,015,000USD-6,430,000USD-2,713,000USD-1,838,000USD-3,807,000USD-1,393,000USD-1,672,000USD
    Free Cash Flow30,179,000USD38,813,000USD24,170,000USD-10,995,000USD29,913,000USD25,032,000USD23,682,000USD
    Total Cashflows From Investing Activities-6,864,000USD-18,798,000USD-2,713,000USD-1,838,000USD-3,807,000USD-1,393,000USD-1,672,000USD
    Net Borrowings-1,250,000USD-6,250,000USD-6,250,000USD84,375,000USD-5,000,000USD-5,000,000USD44,189,000USD
    Total Cash From Financing Activities-43,555,000USD-76,083,000USD-14,380,000USD63,460,000USD-20,343,000USD-18,319,000USD-13,553,000USD
    Dividends Paid-1,727,000USD-4,744,000USD-8,694,000USD-12,886,000USD-11,402,000USD-13,319,000USD-56,634,000USD
    Sale Purchase Of Stock-3,365,000USD-5,599,000USD14,524,000USD-424,000USD0USD——
    Issuance Of Capital Stock142,000USD282,000USD286,000USD442,000USD0USD——
    Change In Cash-15,219,000USD-49,660,000USD9,771,000USD52,465,000USD9,558,000USD6,722,000USD10,120,000USD
    Begin Period Cash Flow39,342,000USD89,002,000USD79,231,000USD26,766,000USD17,208,000USD10,486,000USD366,000USD
    End Period Cash Flow24,123,000USD39,342,000USD89,002,000USD79,231,000USD26,766,000USD17,208,000USD10,486,000USD
    Other Cashflows From Investing Activities-1,849,000USD-526,000USD-2,354,000USD-1,505,000USD-2,359,000USD-1,098,000USD-968,000USD
    Other Cashflows From Financing Activities-37,581,000USD-59,772,000USD420,000USD116,953,000USD-3,941,000USD-1,393,000USD63,184,000USD
    Unclassified Operating Cash Flow3,975,000USD-2,898,000USD—————
    Investments—-18,798,000USD-22,020,000USD-1,838,000USD-3,807,000USD-1,393,000USD-1,672,000USD
    Unclassified Investing Cash Flow—6,956,000USD24,374,000USD3,343,000USD6,166,000USD2,491,000USD2,640,000USD
    Unclassified Financing Cash Flow——-14,380,000USD-124,558,000USD—1,393,000USD-64,292,000USD
    Change To Liabilities———384,000USD1,232,000USD-1,761,000USD1,392,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductContract Term Services Revenue332,000USD0001193125-26-216780
    Q1 2026Quarterly · 2026-03-31ProductDisposable Trocars Product Revenue1,130,000USD0001193125-26-216780
    Q1 2026Quarterly · 2026-03-31ProductOther Service Revenue578,000USD0001193125-26-216780
    Q1 2026Quarterly · 2026-03-31ProductPellet Procedures Product Revenue31,294,000USD0001193125-26-216780
    Q1 2026Quarterly · 2026-03-31ProductProduct Revenue — Dietary Supplements11,037,000USD0001193125-26-216780
    Q1 2026Quarterly · 2026-03-31ProductShipping Fees And Other Product Revenue434,000USD0001193125-26-216780
    Q1 2026Quarterly · 2026-03-31ProductTraining Service Revenue130,000USD0001193125-26-216780
    Q4 2025Quarterly · 2025-12-31ProductContract Term Services Revenue346,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductDisposable Trocars Product Revenue1,207,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductOther Service Revenue583,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductPellet Procedures Product Revenue31,826,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct Revenue — Dietary Supplements11,684,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductShipping Fees And Other Product Revenue572,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductTraining Service Revenue190,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductContract Term Services Revenue1,362,000USD0001193125-26-106099
    FY 2025Yearly · 2025-12-31ProductDisposable Trocars Product Revenue4,852,000USD0001193125-26-106099
    FY 2025Yearly · 2025-12-31ProductOther Service Revenue2,857,000USD0001193125-26-106099
    FY 2025Yearly · 2025-12-31ProductPellet Procedures Product Revenue137,038,000USD0001193125-26-106099
    FY 2025Yearly · 2025-12-31ProductProduct Revenue — Dietary Supplements42,884,000USD0001193125-26-106099
    FY 2025Yearly · 2025-12-31ProductShipping Fees And Other Product Revenue2,150,000USD0001193125-26-106099
    FY 2025Yearly · 2025-12-31ProductTraining Service Revenue1,076,000USD0001193125-26-106099
    Q3 2025Quarterly · 2025-09-30ProductContract Term Services Revenue343,000USD0001193125-25-272294
    Q3 2025Quarterly · 2025-09-30ProductDisposable Trocars Product Revenue1,241,000USD0001193125-25-272294
    Q3 2025Quarterly · 2025-09-30ProductOther Service Revenue433,000USD0001193125-25-272294
    Q3 2025Quarterly · 2025-09-30ProductPellet Procedures Product Revenue33,965,000USD0001193125-25-272294
    Q3 2025Quarterly · 2025-09-30ProductProduct Revenue — Dietary Supplements11,181,000USD0001193125-25-272294
    Q3 2025Quarterly · 2025-09-30ProductShipping Fees And Other Product Revenue566,000USD0001193125-25-272294
    Q3 2025Quarterly · 2025-09-30ProductTraining Service Revenue227,000USD0001193125-25-272294
    Q2 2025Quarterly · 2025-06-30ProductContract Term Services Revenue338,000USD0000950170-25-105800
    Q2 2025Quarterly · 2025-06-30ProductDisposable Trocars Product Revenue1,229,000USD0000950170-25-105800
    Q2 2025Quarterly · 2025-06-30ProductOther Service Revenue535,000USD0000950170-25-105800
    Q2 2025Quarterly · 2025-06-30ProductPellet Procedures Product Revenue35,205,000USD0000950170-25-105800
    Q2 2025Quarterly · 2025-06-30ProductProduct Revenue — Dietary Supplements10,749,000USD0000950170-25-105800
    Q2 2025Quarterly · 2025-06-30ProductShipping Fees And Other Product Revenue474,000USD0000950170-25-105800
    Q2 2025Quarterly · 2025-06-30ProductTraining Service Revenue333,000USD0000950170-25-105800
    Q1 2025Quarterly · 2025-03-31ProductContract Term Services Revenue335,000USD0001193125-26-216780
    Q1 2025Quarterly · 2025-03-31ProductDisposable Trocars Product Revenue1,175,000USD0001193125-26-216780
    Q1 2025Quarterly · 2025-03-31ProductOther Service Revenue1,306,000USD0001193125-26-216780
    Q1 2025Quarterly · 2025-03-31ProductPellet Procedures Product Revenue36,042,000USD0001193125-26-216780
    Q1 2025Quarterly · 2025-03-31ProductProduct Revenue — Dietary Supplements9,270,000USD0001193125-26-216780
    Q1 2025Quarterly · 2025-03-31ProductShipping Fees And Other Product Revenue538,000USD0001193125-26-216780
    Q1 2025Quarterly · 2025-03-31ProductTraining Service Revenue326,000USD0001193125-26-216780
    Q4 2024Quarterly · 2024-12-31ProductContract Term Services Revenue359,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductDisposable Trocars Product Revenue1,121,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOther Service Revenue876,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPellet Procedures Product Revenue36,595,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct Revenue — Dietary Supplements10,071,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductShipping Fees And Other Product Revenue501,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductTraining Service Revenue311,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductContract Term Services Revenue1,226,000USD0001193125-26-106099
    FY 2024Yearly · 2024-12-31ProductDisposable Trocars Product Revenue4,345,000USD0001193125-26-106099
    FY 2024Yearly · 2024-12-31ProductOther Service Revenue2,269,000USD0001193125-26-106099
    FY 2024Yearly · 2024-12-31ProductPellet Procedures Product Revenue150,329,000USD0001193125-26-106099
    FY 2024Yearly · 2024-12-31ProductProduct Revenue — Dietary Supplements36,018,000USD0001193125-26-106099
    FY 2024Yearly · 2024-12-31ProductShipping Fees And Other Product Revenue1,548,000USD0001193125-26-106099
    FY 2024Yearly · 2024-12-31ProductTraining Service Revenue1,456,000USD0001193125-26-106099
    Q3 2024Quarterly · 2024-09-30ProductContract Term Services Revenue303,000USD0001193125-25-272294
    Q3 2024Quarterly · 2024-09-30ProductDisposable Trocars Product Revenue1,083,000USD0001193125-25-272294
    Q3 2024Quarterly · 2024-09-30ProductOther Service Revenue702,000USD0001193125-25-272294
    Q3 2024Quarterly · 2024-09-30ProductPellet Procedures Product Revenue37,927,000USD0001193125-25-272294
    Q3 2024Quarterly · 2024-09-30ProductProduct Revenue — Dietary Supplements10,317,000USD0001193125-25-272294
    Q3 2024Quarterly · 2024-09-30ProductShipping Fees And Other Product Revenue479,000USD0001193125-25-272294
    Q3 2024Quarterly · 2024-09-30ProductTraining Service Revenue573,000USD0001193125-25-272294
    Q2 2024Quarterly · 2024-06-30ProductContract Term Services Revenue290,000USD0000950170-25-105800
    Q2 2024Quarterly · 2024-06-30ProductDisposable Trocars Product Revenue1,114,000USD0000950170-25-105800
    Q2 2024Quarterly · 2024-06-30ProductOther Service Revenue470,000USD0000950170-25-105800
    Q2 2024Quarterly · 2024-06-30ProductPellet Procedures Product Revenue38,418,000USD0000950170-25-105800
    Q2 2024Quarterly · 2024-06-30ProductProduct Revenue — Dietary Supplements8,241,000USD0000950170-25-105800
    Q2 2024Quarterly · 2024-06-30ProductShipping Fees And Other Product Revenue338,000USD0000950170-25-105800
    Q2 2024Quarterly · 2024-06-30ProductTraining Service Revenue298,000USD0000950170-25-105800
    FY 2023Yearly · 2023-12-31ProductContract Term Services Revenue920,000USD0000950170-25-039394
    FY 2023Yearly · 2023-12-31ProductDisposable Trocars Product Revenue3,320,000USD0000950170-25-039394
    FY 2023Yearly · 2023-12-31ProductOther Service Revenue697,000USD0000950170-25-039394
    FY 2023Yearly · 2023-12-31ProductPellet Procedures Product Revenue140,991,000USD0000950170-25-039394
    FY 2023Yearly · 2023-12-31ProductProduct Revenue — Dietary Supplements38,090,000USD0000950170-25-039394
    FY 2023Yearly · 2023-12-31ProductShipping Fees And Other Product Revenue172,000USD0000950170-25-039394
    FY 2023Yearly · 2023-12-31ProductTraining Service Revenue1,170,000USD0000950170-25-039394
    FY 2022Yearly · 2022-12-31ProductContract Term Services Revenue851,000USD0000950170-24-032101
    FY 2022Yearly · 2022-12-31ProductDisposable Trocars Product Revenue1,698,000USD0000950170-24-032101
    FY 2022Yearly · 2022-12-31ProductPellet Procedures Product Revenue128,952,000USD0000950170-24-032101
    FY 2022Yearly · 2022-12-31ProductProduct Revenue — Dietary Supplements32,412,000USD0000950170-24-032101
    FY 2022Yearly · 2022-12-31ProductShipping Fees Product Revenue71,000USD0000950170-24-032101
    FY 2022Yearly · 2022-12-31ProductTraining Service Revenue973,000USD0000950170-24-032101
    FY 2021Yearly · 2021-12-31ProductContract Term Services Revenue939,000USD0000950170-23-010664
    FY 2021Yearly · 2021-12-31ProductDisposable Trocars Product Revenue860,000USD0000950170-23-010664
    FY 2021Yearly · 2021-12-31ProductPellet Procedures Product Revenue109,465,000USD0000950170-23-010664
    FY 2021Yearly · 2021-12-31ProductProduct Revenue — Dietary Supplements27,241,000USD0000950170-23-010664
    FY 2021Yearly · 2021-12-31ProductShipping Fees Product Revenue32,000USD0000950170-23-010664
    FY 2021Yearly · 2021-12-31ProductTraining Service Revenue859,000USD0000950170-23-010664

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.